A new paper explores different findings about the development of Alzheimer's and considers how personalized treatments may help combat this complex disease.
A molecular process caused by the TREM2 gene mutation in the brain's microglia increases the risk of Alzheimer's disease, a new study reports.
A two-week course of CBD helps normalize and restore the function of two proteins associated with reducing amyloid-beta accumulation in mouse models of familial Alzheimer's disease. CBD also reduces levels of IL-6, an immune protein associated with inflammation in Alzheimer's patients.
Findings could help in the development of treatments to prevent brain inflammation associated with Alzheimer's disease.
Rapamycin, a drug approved for the treatment of cancer and transplant patients increases amyloid-beta protein plaques in the brains of mice.
Researchers report activating microglia may help reduce the imbalance between neuroprotection and neurotoxicity for neurodegenerative diseases.
Stimulating activation of microglia may help eliminate Alzheimer's associated plaques, thus helping to prevent the progression of the neurodegenerative disease.
Researchers report microglia may actually protect the brain against Alzheimer's disease by containing the spread of amyloid plaques.
Researchers have discovered an early immune response in people with a genetic predisposition to Alzheimer's disease.
